Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market

Arbutus Biopharma (ABUS) Income Statement

Compare
1,236 Followers

Arbutus Biopharma Income Statement

Last quarter (Q4 2024), Arbutus Biopharma's total revenue was $1.57M, a decrease of -26.62% from the same quarter last year. In Q4, Arbutus Biopharma's net income was $-12.53M. See Arbutus Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.17M$ 18.14M$ 39.02M$ 10.99M$ 6.91M
Gross Profit
$ 6.17M$ -55.56M$ 37.59M$ 9.23M$ -40.57M
Operating Expenses
$ 82.49M$ 96.24M$ 102.24M$ 82.64M$ 64.18M
Depreciation and Amortization
$ 1.38M$ 1.40M$ 1.43M$ 1.75M$ 1.98M
EBITDA
$ -68.40M$ -70.99M$ -61.86M$ -71.64M$ -57.81M
Operating Income
$ -76.32M$ -78.10M$ -65.46M$ -73.52M$ -57.81M
Other Income/Expenses
$ 6.40M$ 5.25M$ 444.00K$ -2.73M$ -5.94M
Pretax Income
$ -69.92M$ -72.85M$ -65.01M$ -76.25M$ -63.74M
Net Income
$ -69.92M$ -72.85M$ -69.46M$ -77.35M$ -65.21M
Per Share Metrics
Basic EPS
$ -0.38$ -0.44$ -0.46$ -0.73$ -0.86
Diluted EPS
$ -0.38$ -0.44$ -0.46$ -0.73$ -0.86
Weighted Average Shares Outstanding
185.61M 165.96M 150.94M 106.24M 75.84M
Weighted Average Shares Outstanding (Diluted)
185.61M 165.96M 150.94M 106.24M 75.84M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis